Molecule of the month

Current Topics in Medicinal Chemistry

Volumn 7, Issue 16, 2007, Pages 1643-

  Bolinger, Julie D ^a,b   Lindsley, Craig W ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVAIR DISKUS; ATORVASTATIN; CLOPIDOGREL; ESOMEPRAZOLE; ETANERCEPT; FLUTICASONE PROPIONATE PLUS SALMETEROL; GENERIC DRUG; LANSOPRAZOLE; MELOXICAM; MONTELUKAST; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; QUETIAPINE; RECOMBINANT ERYTHROPOIETIN; SERTRALINE; SIMVASTATIN; UNCLASSIFIED DRUG;

ARTICLE; COMPETITION; COST CONTROL; DRUG COST; DRUG EFFICACY; DRUG INDUSTRY; DRUG MARKETING; DRUG SAFETY; DRUG STRUCTURE; MEDICARE; PATENT; PHARMACEUTICAL CARE; PRESCRIPTION;

EID: 36249020998     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802607782341118     Document Type: Article

References (3)

1. Lamb, E. Top 200 prescription drugs of 2006. Pharmacy Times, May 2007, pp. 1-4, and reference therein.
2. IMS Health. Press release. March 8, 2007, www.imshealth.com
3. For more information on generic drug approvals and impact on sales see the US Food and Drug Adminstration: www.fda.gov